People on weight loss drugs are being urged to shop around, with research suggesting some are paying more than they need to for pills or injections.
Recap by typeshit. Post by Facebook on Facebook.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
BoxLife recaps the ranking: retatrutide gets B, BPC-157 low C, NAD+ D and epitalon F. Exercise is the only thing Nippard puts in S tier.
Industry sources put the first four weeks at about 129,800 won wholesale, roughly half of Mounjaro's starting cost. Launch is expected later this month.
Loading…